Investing.com - Avita Medical reported on Monday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Avita Medical announced earnings per share of $-0.24 on revenue of $7.02M. Analysts polled by Investing.com anticipated EPS of $-0.38 on revenue of $7.1M.
Avita Medical shares are up 4.36% from the beginning of the year and are trading at $19.38 , down-from-52-week-high.They are under-performing the Nasdaq which is up 24.01% from the start of the year.
Avita Medical shares lost 0.05% in after-hours trade the report.
Avita Medical follows other major Healthcare sector earnings this month
Avita Medical's report follows an earnings beat by J&J on Tuesday, October 19, 2021, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Pfizer had beat expectations on Tuesday, November 2, 2021 with third quarter EPS of $1.34 on revenue of $24.09B, compared to forecast for EPS of $1.08 on revenue of $22.58B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar